Pharmaron Beijing Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Pharmaron Beijing Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 16 Nov 2021 | Lorem |
| Pharmaron works as CRO on investigator-led preclinical RET inhibitor program | 12 Feb 2019 | Manasi Vaidya |
| Pharma demand for complex manufacturing and formulation services to drive CMO contracts and acquisitions | 19 May 2016 | Fiona Barry |
| Savant's Chagas disease compound is GMP version of long-marketed drug - CEO | 10 Apr 2014 | Natalie Morrison |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer